CNTY-102

N/A

Report date: 2024/11/14 15:48:34

Base Information

Drug NameCNTY-102
Drug Alias NameCNTY102
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionB-lymphocyte antigen CD19 modulatorsB-cell antigen receptor complex-associated protein beta chain modulators
TargetsB-lymphocyte antigen CD19B-cell antigen receptor complex-associated protein beta chain
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentury Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesCentury Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A